The proportion of elderly persons who have received an influenza vaccination has been at a plateau since 1997, when the vaccination rate for elderly persons was only 65.5% [14] . Current estimates show no significant improvement, with a vaccination rate of 65.7% for January through September 2002 [15] . Vaccination rates for elderly persons who report poor health (69.4% in 1999) or who have diabetes (72.6% in 1999) are somewhat higher than those for other elderly persons [14] , but even the vaccination rates for those likely to be at especially high risk remain substantially below the national health goal. Furthermore, in the United States, deaths due to influenza have increased over the past 20 years, with 190% of these deaths occurring among elderly persons [2] .
To make significant progress in the prevention and control of influenza among elderly persons, vaccine delivery efforts must become more effective. These efforts might include improved attempts to address barriers to vaccination. Among the barriers to vaccination are uncertainties among health care providers and their high-risk patients about the risk of serious influenza-related complications and the benefits of vaccination [16] [17] [18] [19] . Recent data from a survey of Medicare beneficiaries, for example, suggest that lack of awareness of personal risk is among the most common reasons for failing to receive the influenza vaccine [20] . Among health care providers, a patient's risk of illness is among the most important factors that influence the health care provider's recommendations with regard to vaccination. However, despite an abundance of evidence establishing the increased risk of serious influenza-associated complications among elderly persons, in a recent national survey, 14% of generalist physicians and 25% of medical subspecialty physicians did not "very strongly" recommend vaccination to their elderly patients [21] .
A risk-assessment tool based on a simple, accurate, objective prognostic model might help both patients and health care providers to better assess and appreciate the risks associated with influenza and the potential benefits of vaccination. This type of instrument might therefore provide useful information to complement current age-based strategies and encourage higher levels of vaccination, particularly among those at the highest risk of a serious influenza-associated complication. We developed and validated such a tool, using demographic and clinical information from the administrative databases of 3 large managed care organizations. The prediction rule was based on the performance of multivariate models for predicting an outcome (hospitalization due to pneumonia or influenza or death due to any cause) in cohorts of 111,000 elderly members of the health plans, for both of the derivation cohorts, as well as for 11 validation cohorts spanning the 1996-1997 and 1997-1998 influenza seasons.
SUBJECTS AND METHODS

Setting.
The present study is part of an ongoing collaborative effort between 3 large managed care organizations from geographically disparate locations across the United States. Data from the administrative and clinical databases of each plan are pooled to provide assessments of the effect of influenza and the health and economic benefits of vaccination among members of the health care plans. HealthPartners (HP) is a nonprofit health maintenance organization (HMO) with ∼890,000 members in Minnesota and Wisconsin. It offers coverage for 280,000 members through a staff-model HMO, whereas the other members are covered through a network-model HMO. Kaiser Permanente Northwest Division provides medical care for ∼420,000 persons in the Portland, Oregon; Vancouver; and Washington regions. Oxford Health Plans provides health benefit plans to 1.8 million members in New York, New Jersey, Pennsylvania, and Connecticut. In all, 13 million members receive medical care from these health plans. The health plans used uniform protocols and definitions of comorbidity and outcomes for obtaining all study data. Elsewhere, we have reported on the effectiveness of influenza vaccination among all elderly members of these HMOs [22] and among elderly members with and without certain chronic medical conditions [23] , for the 1996-1997 and 1997-1998 influenza seasons, as well as the effectiveness of vaccination for reducing hospitalization due to cardiac disease or stroke for the 1998-1999 and 1999-2000 influenza seasons [24] .
Study subjects. All noninstitutionalized members of the 3 health plans who were 165 years old on 1 October 1996 in the first year and 1 October 1997 in the second year and who were continuously enrolled for у12 months before 1 October of each year and were enrolled throughout the subsequent influenza season were included in the study cohorts. This enrollment period was chosen to ensure valid prognostic information to derive and validate the regression model. For Oxford Health Plans, only data for members living in New York City and the surrounding counties were collected, since the data available for the other sites were less complete. Institutionalized patients were excluded from all sites because vaccination status recorded in the administrative databases was less accurately captured.
Definitions of potential predictors. After searching the medical literature, we selected 15 clinical characteristics that could be related to clinical outcomes during influenza epidemics. The following potential predictors, which represent baseline characteristics of the subjects, were included: age, sex, hospitalization due to influenza or pneumonia, and number of outpatient visits during the previous year. Preexisting medical conditions of eligible subjects were classified according to entries of relevant codes in the Influenza seasons and vaccination. The 1996-1997 and 1997-1998 influenza seasons were characterized by epidemic levels of influenza activity that peaked in most parts of the country during early (1996-1997) and late (1997-1998) January [25, 26] . The influenza periods were defined as extending from the date of the first influenza isolate to the date of the last influenza isolate, on the basis of the Centers for Disease Control and Prevention surveillance data, for the regions corresponding to the HMOs [22, 23] . Vaccination status was determined for the corresponding vaccination season from the databases, as defined by Current Procedural Terminology, Fourth Edition, code 90657 or any site-specific flags in the clinical databases.
Outcomes. Hospitalizations due to pneumonia or influenza or mortality during influenza seasons are highly correlated [1] . To maximize the number of outcomes assessed and thereby to enhance the power of the study, we used a combined outcome of hospitalization due to pneumonia or influenza (ICD-9-CM codes 480-487) or death due to all causes during the influenza seasons studied. Development of the model. To develop the model, we used the data on the 16,280 unvaccinated subjects from the HP database who were enrolled during the first influenza season. Age was classified into the following 5 categories, according to exponential increase in risk of outcomes: 65-69 (0.8% with an outcome), 70-74 (1.4% with an outcome), 75-79 (2.5% with an outcome), 80-89 (4.2% with an outcome), and у90 years old (8.1% with an outcome). Similarly, the number of outpatient visits during the previous 12 months was classified into 4 categories: 0 (0.9% with an outcome), 1-6 (1.0% with an outcome), 7-12 (1.6% with an outcome), and у13 visits (5.6% with an outcome). Descriptive statistics, which were expressed as proportions and means (‫ע‬SD) and were determined by use of SPSS software (version 9.0, SPSS), were calculated to compare baseline characteristics between those with and those without an outcome. The construction of the prognostic model started with a univariate assessment of the prognostic effect of each characteristic separately, given as odds ratios (ORs) and their 95% confidence intervals (CIs), by use of logistic-regression analysis. In the next stage, we used multivariate logisticregression modeling with a backward elimination procedure to select those variables that were related to the outcome, with as a criterion for selection. We first used the continuous P ! .15 variables age and number of outpatient visits to ensure that the selection of the corresponding classified variables was independent of the choice of the cutoff values. Forward selection was additionally performed to verify whether any previously deleted, potentially relevant characteristics were incorrectly eliminated from the model. The models yielded similar predictors. Interaction between variables included in the model was assessed to determine deviations from the additivity assumption by including first-order interaction terms in the final model. For each patient, we calculated the individual probability of the outcome from the final model (predicted probability).
Evaluation of the model. The reliability of the multivariate logistic-regression model derived from the derivation cohort was determined by use of the Hosmer-Lemeshow goodness-offit statistic [27] . The area under the receiver-operating curve (ROC) was used to assess the model's discriminative ability [28] . The ROC is a plot of the true-positive rate (sensitivity) and the false-positive rate (
) and is evaluated for 1 Ϫ specificity each cutoff point of the predicted probability. The area under the ROC can be explained as the probability that the logisticregression model will assign a higher probability of the outcome to a randomly chosen patient with an outcome than to a randomly chosen patient without an outcome. An area under the curve (AUC) estimate of 0.5 indicates no discrimination, whereas an AUC estimate of 1.0 indicates perfect discrimination. Values between 0.70 and 0.79 indicate fair discrimination, and a value у0.80 indicates good discrimination. External validation of the model was performed by comparing the AUC values across the other 11 cohorts, which were stratified by vaccination status, site, and year.
Development and applicability of the prediction rule. The regression coefficients of the derived multivariate model were used to construct the prediction rule [29, 30] . The predicted probability of outcome was determined as , ϪLP 1/(1 + e ) where the linear predictor (LP) p Ϫ6.0906 + (0.4681 ϫ age category) + (0.2939 ϫ male sex) + (2.0872 ϫ previous hospitalization due to pneumonia or influenza) + (0.3794 ϫ outpatient visits category) + (0.6012 ϫ pulmonary disease) + (0.1952 ϫ heart disease) + (0.4135 ϫ renal disease or transplant) + (0.7273 ϫ dementia or stroke) + (1.5887 ϫ cancer). The absence or presence of specific characteristics was coded as 0 (absent) or 1 (present). To simplify interpretation, we multiplied the regression coefficients by 30 and rounded them to form the score value. The scores for individual prognostic variables were added to form the prognostic score (minimum 0 to maximum 267 points) for an outcome. For prognostic score cutoff points, the following test characteristics were calculated: positive predictive value, sensitivity, specificity, proportion of outcomes missed ( ), and proportion of subjects 1 Ϫ sensitivity having the cutoff score or higher.
Vaccine effectiveness. To assess whether vaccine effectiveness varied by prognostic score (high vs. low score), we calculated the vaccine effectiveness for the elderly persons in both risk subgroups, using logistic regression. In this analysis, vaccine effectiveness was adjusted for potential confounding by the other predictors (age, sex, number of outpatient visits, hospitalization, comorbidities, site, and year). Vaccine effectiveness was determined as . The absolute risk reduction 1 Ϫ OR ϫ 100% [31] per 1000 vaccinated subjects was calculated by multiplying the vaccine effectiveness by the incidence of the outcome in unvaccinated subjects.
RESULTS
Of the 16,280 study subjects in the derivation cohort, 399 (2.5%) were hospitalized or died during the influenza season.
The mean age was 75 years (SD, 8 years; range, 65-110 years), and 38% were male. One or more of the preexisting high-risk medical conditions was present in 47% of subjects.
In univariate analysis, all potential predictors appeared to be more prevalent among subjects who were hospitalized or died and were statistically significantly associated with the combined outcome, except for history of immunodeficiency (table 1) . Among elderly persons who were hospitalized or died, we observed markedly higher prevalences of previous hospitalization due to pneumonia or influenza (16% vs. 1%), pulmonary disease (40% vs. 14%), dementia or stroke (31% vs. 9%), and cancer (12% vs. 2%), compared with control subjects.
Except for history of diabetes, anemia, nutritional deficiencies, vasculitis or rheumatological disorders, immunodeficiency, and cirrhosis, all the other variables independently contributed to the multivariate logistic-regression model (table 1). In the modeling procedure, the addition of these nonrelated diseases to a partial model that included age, sex, previous hospitalization due to pneumonia or influenza, and number of outpatient visits did not significantly contribute to the model. Likewise, when these variables were added to the complete model that included all other variables that were significantly and independently associated with an outcome, they did not significantly contribute to the model ( ). Thus, these var-P 1 .15 iables were not included in the final prognostic model.
After including first-order interaction terms in the final model, 6 terms were statistically significant: gender ϫ dementia or stroke, heart disease ϫ cancer, age ϫ heart disease, age ϫ hospitalization, pulmonary disease ϫ hospitalization, and dementia or stroke ϫ hospitalization. Although it may be clinically plausible that risks of these combinations are more than additive, compared with the risks of each separate variable, we did not include them in the final prognostic model for 3 reasons: (1) these interactions were not observed in earlier studies, although they used much smaller cohorts than those in the present study (E.H., unpublished data); (2) they were not statistically significant in the 5 other unvaccinated and 6 other vaccinated cohorts with 111,000 subjects; and (3) they did not materially contribute to the discriminative value of the model. Performance of the final model was good ( , by goodness-of-fit test). P p .65 The model discriminated well between those with an outcome (predicted probability ‫ע‬ SD, ) and those without an 10% ‫ע‬ 1% outcome (predicted probability ‫ע‬ SD, ). The AUC 0.2% ‫ע‬ 0.4% was 0.83 (95% CI, 0.81-0.85; figure 1) .
AUC estimates were moderately lower but were acceptable across the validation cohorts (see table 2 ; range, 0.72-0.81). The average discriminative power was ∼0.05 points lower in the second season, compared with the first season, and was 0.03 points lower in vaccinated subjects, compared with unvaccinated subjects.
The prediction rule was derived from the final multivariate model in which a score was assigned to the presence or level of each variable (table 3) . A prognostic score for each patient, reflecting the probability of reaching an outcome, was calculated by adding the scores of relevant characteristics. For instance, the prognostic score for a 66-year-old man with Hodgkin disease who had visited the outpatient clinic 7 times during the previous year and had recently been diagnosed with asthma is 97 ( ), which represents a risk that is 25.5 times 9 + 48 + 22 + 18 higher than that of the lowest risk category (table 4) .
The prediction rule can be used to estimate an individual's risk of hospitalization due to pneumonia or influenza or death due to any cause during the influenza season. Using the derivation cohort for each cutoff level of the prognostic score, we calculated test characteristics (table 4) . A cutoff score of у50 for defining higher risk had a sensitivity of 89% (89 of 100 outcomes occurred in this group, whereas 11 of 100 occurred among subjects with a score of !50). Patients with lower-risk assignment (score of !50) had an observed average probability of 0.5% for experiencing an outcome, whereas those with higher risk (score of у50) had an average probability of 4.1% for experiencing an outcome. With increasing cutoff levels for defining higher risk, the proportion of persons classified as lower risk would increase, but the proportion of outcomes occurring among the lower-risk persons would also increase. To optimize the trade-offs between sensitivity and specificity, we selected a score of у50 for defining higher risk, and this optimization held for the validation cohorts as well (table 5) . When the test characteristics for both outcomes were analyzed separately, results were similar (data not shown).
Vaccine effectiveness was similar among subjects with higherrisk and those with lower-risk assessments (43% [95% CI, 39%-47%] and 33% [95% CI, 24%-45%], respectively). The observed outcome event rates among unvaccinated subjects combined were 35 events/1000 higher-risk subjects and 6 events/1000 lower-risk subjects. The absolute risk reduction seen with vaccination was estimated to be 15 events/1000 sub- Heart disease 6
Renal disease or transplant 12
Dementia or stroke 22
Nonhematological and hematological cancer 48 a The prognostic score for a given subject can be obtained by adding the scores for each applicable characteristic. The prognostic score correlates with the predicted probability through the formula presented in Subjects and Methods.
jects and 2 events/1000 subjects, respectively. Thus, the absolute reduction in outcomes was greater in the higher-risk group.
DISCUSSION
The present study is unique because we were able to derive and validate a prediction rule with acceptable reliability, discriminating ability, and generalizibility using data on large cohorts of elderly persons from 3 geographically disparate health plans across the United States. Our prediction rule has distinctive strengths. We developed a 9-factor prognostic scoring system in nonselected persons, using information on predictors that can be readily assessed by both patients and health care providers. In addition, the reliability, accuracy, and generalizibility of the rule are supported by derivation in 16,280 elderly persons and by validation in 11 large external cohorts representing other areas across the United States, different epidemic seasons, and vaccination status. Many of the predictors incorporated in our prediction rule have been established in earlier epidemiological studies as risk factors for potential influenza-associated complications [5] [6] [7] [8] [9] [10] [11] [32] [33] [34] [35] . Increasing age has been associated with increased risk of hospitalization due to pneumonia [36] . Men have been found to be at higher risk than women for hospitalization [36, 37] and death due to pneumonia [38] . Rates of hospitalization due to chronic respiratory conditions or congestive heart failure increase during influenza seasons, and persons with underlying heart and pulmonary disease are at increased risk of these complications from influenza [7, 8, 11, 39] . Patients with renal transplants receive immunosuppressive medication, which puts them at risk of infections [40] . Patients with cancer have a higher risk of dying due to pneumonia [38, 41] . Previous hospitalization has also been identified as a risk factor [42, 43] . In some studies, preexisting neurologic diseases (e.g., dementia or stroke) have also been reported to be associated with an increased risk of pneumonia-related mortality [38, 41] .
Persons with diabetes have higher mortality due to pneumonia or influenza than do persons in the general population [44] . However, in the present study, diabetes per se was not independently associated with a higher risk of hospitalization due to pneumonia or influenza or death, in either the derivation or validation cohorts, which is in accordance with the results of a case-control study in The Netherlands [45] . Other characteristics of patients-such as the presence of anemia, cirrhosis, immunodeficiency, vasculitits, or nutritional deficiencyalso were not independent predictors. However, most of the patients with these conditions also had either a higher-thanaverage age or another condition placing them at higher risk. Thus, the presence of these diseases generally occurred among persons who were otherwise at higher risk.
It is of interest to note that the validity of the prediction rule carried over to a second influenza season and was also predictive of persistent risk of adverse outcomes, even among vaccinated subjects, although the absolute event rates were substantially lower after vaccination. We believe, therefore, that results are applicable to future seasons and other settings. In addition, the findings may have relevance for treatment in persons who develop influenza, regardless of vaccination status.
A patient's understanding of their personal risk of illness is consistently identified as an important determinant of whether that patient will receive a vaccination [16] [17] [18] [19] [20] . We anticipate that, for patients, a clinical prediction rule such as the one that we have developed could serve as a useful tool to help clarify the nature of personal risk and the degree of protection against serious complications of influenza that they might experience as a result of vaccination; for health care providers, it may also help to reinforce the serious nature of influenza and the importance of ensuring that all high-risk patients are vaccinated. Settings in which this rule might be used ideally include medical subspecialty clinics. Most elderly patients seen in such settings likely will fall into the higher-risk subgroup, and, thus, for these patients, the rule should help to reinforce the need for vacci- NOTE. OM, outcomes missed (proportion of outcomes occurring among subjects with a score less than the indicated cutoff point); OP, observed probability of outcome among subjects having a score within the indicated score category; PPV, positive predictive value for an outcome among subjects having a score greater or equal to the cutoff point; RR, relative risk (!10 points is the reference); SE, sensitivity; Selection, the percentage of the cohort having a score greater or equal to the indicated cutoff point; SP, specificity.
nation. In addition, medical subspecialists are less likely to recommend vaccination to their high-risk patients or to use effective strategies to ensure that their patients are vaccinated [21] . For health care providers, the use of a clinical prediction rule might therefore also help to highlight the critical nature of taking advantage of all opportunities to offer and administer vaccine to patients.
Persons in the lower-risk subgroup are also at increased risk of serious complications from influenza, and the clinical prediction rule should not be used to discourage healthy elderly persons from being vaccinated. The event rates that we observed among unvaccinated subjects in the lower-risk subgroup are ∼10-30 times higher than those reported for low-risk subjects !65 years old (excess hospitalization rates of 0.2-0.4 excess hospitalizations/1000 low-risk subjects !65 years old [3] and excess death rates of 0.015-0.125 excess deaths/1000 subjects 5-64 years old [2] vs. a combined end-point event rate of 6 events/1000 unvaccinated lower-risk elderly persons [data from the present study]). Our findings, therefore, clearly support current age-based recommendations for the vaccination of all persons у65 years old. Vaccination of healthy persons 65-74 years old has elsewhere been reported to be highly cost-effective and even cost saving [46] .
For the development of the clinical prediction rule, we studied only persons у65 years old. The majority of excess deaths and many of the excess hospitalizations due to influenzaassociated complications occur in this group. However, highrisk persons !65 years old are also included among the priority groups targeted for vaccination. Vaccination rates for these high-risk persons have lagged behind those for persons у65 years old. Because a substantial percentage of persons 50-64 years old also have a high-risk medical condition, and, in light of the success of age-based recommendations, the Advisory Committee on Immunization Practices has lowered its agebased recommendations for annual vaccination to 50 years old [3] . How our prediction rule might apply to persons 50-64 years old or to other high-risk persons !65 years old is unclear. Since we studied only community-dwelling elderly persons, it is also unclear how our findings might relate to institutionalized persons.
We used hospitalization due to pneumonia or influenza and death due to all causes as the outcomes for the prediction rule. These outcomes are highly correlated during influenza seasons and have traditionally been among the main measures used to assess and define the magnitude and effect of influenza epidemics [1] . These outcome measures, however, are also nonspecific with regard to a causal relation to antecedent influenza infection or illness. Thus, the expected level of vaccine effectiveness (in the present study, 33%-43%) is lower than might be observed with more-specific influenza-associated outcomes, such as laboratory-confirmed illness. In addition, influenza may also be responsible for a wide range of other complications, including exacerbations of underlying medical conditions leading to increased outpatient and inpatient health care use [11] . It is not clear how the results of our model might apply to these other outcomes.
Vaccination status for the present study was recorded as a categorical variable (i.e., as either present or absent) because, in some of the databases, the date of vaccination was not recorded. Therefore, it is possible that, in some cases, a subject was vaccinated after they were hospitalized. Influenza activity peaked in late December/early January during the 1996-1997 influenza season [25] and in late January/early February during the 1997-1998 influenza season [26] . Among Medicare bene- NOTE. Data are %. OM, outcomes missed (proportion of outcomes occurring among subjects with a score of !50); PPV, positive predictive value for an outcome among subjects having a score of у50; SE, sensitivity; Selection, the percentage of the cohort having a score greater or equal to the indicated cutoff point; SP, specificity.
a The derivation cohort ( ). n p 16, 280 ficiaries who received influenza vaccinations in 1998 or 1999, ∼97% were vaccinated before December [47] . Anecdotal data suggest that the timing of vaccinations for the subjects included in the present study followed a similar pattern (K.L.N., unpublished data). Thus, it is likely that most, if not virtually all, influenza-associated outcomes occurred after vaccination. Furthermore, the decision rule was developed in an unvaccinated cohort with adequate performance of the decision rule, with validation in multiple vaccinated and unvaccinated cohorts over the course of 2 seasons. The decision rule performed similarly, regardless of vaccination status or study year. Accordingly, we feel that misclassification of vaccination status is unlikely to have substantially influenced the findings of the present study. The most likely effect, if any, would have been to bias estimates of vaccine effectiveness toward the null.
In conclusion, we derived and validated a prediction rule for quantifying the probability of hospitalization due to pneumonia or influenza or death due to any cause among communitydwelling elderly persons during influenza seasons, with acceptable reliability, discriminating ability, and generalizibility. In light of static vaccination rates and despite increasing influenza-associated mortality rates among elderly persons, the use of a tool such as this one may represent another strategy to complement other, age-based strategies, to aid practitioners as they attempt to ensure that high-risk patients are vaccinated.
